Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

94 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Rosiglitazone decreases albuminuria in type 2 diabetic patients.
Miyazaki Y, Cersosimo E, Triplitt C, DeFronzo RA. Miyazaki Y, et al. Kidney Int. 2007 Dec;72(11):1367-73. doi: 10.1038/sj.ki.5002516. Epub 2007 Sep 5. Kidney Int. 2007. PMID: 17805239 Clinical Trial.
Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes.
Bajaj M, Suraamornkul S, Pratipanawatr T, Hardies LJ, Pratipanawatr W, Glass L, Cersosimo E, Miyazaki Y, DeFronzo RA. Bajaj M, et al. Diabetes. 2003 Jun;52(6):1364-70. doi: 10.2337/diabetes.52.6.1364. Diabetes. 2003. PMID: 12765945
Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients.
Bajaj M, Suraamornkul S, Piper P, Hardies LJ, Glass L, Cersosimo E, Pratipanawatr T, Miyazaki Y, DeFronzo RA. Bajaj M, et al. J Clin Endocrinol Metab. 2004 Jan;89(1):200-6. doi: 10.1210/jc.2003-031315. J Clin Endocrinol Metab. 2004. PMID: 14715850
Comparison of glargine insulin versus rosiglitazone addition in poorly controlled type 2 diabetic patients on metformin plus sulfonylurea.
Triplitt C, Glass L, Miyazaki Y, Wajcberg E, Gastaldelli A, De Filippis E, Cersosimo E, DeFronzo RA. Triplitt C, et al. Diabetes Care. 2006 Nov;29(11):2371-7. doi: 10.2337/dc06-0564. Diabetes Care. 2006. PMID: 17065670 Clinical Trial.
Comprehensive assessment of postischemic vascular reactivity in Hispanic children and adults with and without diabetes mellitus.
Wajcberg E, Thoppil N, Patel S, Fernandez M, Hale D, DeFronzo R, Cersosimo E. Wajcberg E, et al. Pediatr Diabetes. 2006 Dec;7(6):329-35. doi: 10.1111/j.1399-5448.2006.00209.x. Pediatr Diabetes. 2006. PMID: 17212600
Relationship between vascular reactivity and lipids in Mexican-Americans with type 2 diabetes treated with pioglitazone.
Wajcberg E, Sriwijitkamol A, Musi N, DeFronzo RA, Cersosimo E. Wajcberg E, et al. J Clin Endocrinol Metab. 2007 Apr;92(4):1256-62. doi: 10.1210/jc.2006-1910. Epub 2007 Jan 23. J Clin Endocrinol Metab. 2007. PMID: 17244785 Clinical Trial.
Effects on insulin secretion and insulin action of a 48-h reduction of plasma free fatty acids with acipimox in nondiabetic subjects genetically predisposed to type 2 diabetes.
Cusi K, Kashyap S, Gastaldelli A, Bajaj M, Cersosimo E. Cusi K, et al. Am J Physiol Endocrinol Metab. 2007 Jun;292(6):E1775-81. doi: 10.1152/ajpendo.00624.2006. Epub 2007 Feb 13. Am J Physiol Endocrinol Metab. 2007. PMID: 17299078 Clinical Trial.
Elevated plasma FFA cause beta-cell lipotoxicity and impair insulin secretion in nondiabetic subjects predisposed to type 2 diabetes mellitus [T2DM; i.e., with a strong family history of T2DM (FH+)] but not in nondiabetic subjects without a family history of T2DM. ...
Elevated plasma FFA cause beta-cell lipotoxicity and impair insulin secretion in nondiabetic subjects predisposed to type 2 diabetes mellitu …
Effect of acute exercise on AMPK signaling in skeletal muscle of subjects with type 2 diabetes: a time-course and dose-response study.
Sriwijitkamol A, Coletta DK, Wajcberg E, Balbontin GB, Reyna SM, Barrientes J, Eagan PA, Jenkinson CP, Cersosimo E, DeFronzo RA, Sakamoto K, Musi N. Sriwijitkamol A, et al. Diabetes. 2007 Mar;56(3):836-48. doi: 10.2337/db06-1119. Diabetes. 2007. PMID: 17327455 Free PMC article. Clinical Trial.
94 results
Jump to page
Feedback